Annual ROE:
-60.44%+420.91%(+87.44%)Summary
- As of today (October 8, 2025), AVDL annual return on equity is -60.44%, with the most recent change of +420.91% (+87.44%) on December 31, 2024.
- During the last 3 years, AVDL annual ROE has risen by +3.86% (+6.00%).
- AVDL annual ROE is now -153.12% below its all-time high of 113.79%, reached on December 31, 2019.
Performance
AVDL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-3.81%+31.76%(+89.29%)Summary
- As of today (October 8, 2025), AVDL quarterly return on equity is -3.81%, with the most recent change of +31.76% (+89.29%) on June 1, 2025.
- Over the past year, AVDL quarterly ROE has increased by +104.64% (+96.49%).
- AVDL quarterly ROE is now -100.50% below its all-time high of 755.56%, reached on March 31, 2023.
Performance
AVDL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVDL ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | +87.4% | +96.5% |
3Y3 Years | +6.0% | +98.0% |
5Y5 Years | -153.1% | -105.8% |
AVDL ROE Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | at high | +87.5% | -100.5% | +99.6% |
5Y | 5-Year | -153.1% | +87.5% | -100.5% | +99.6% |
All-Time | All-Time | -153.1% | +94.8% | -100.5% | +99.9% |
AVDL ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | -3.81%(+89.3%) |
Mar 2025 | - | -35.57%(+43.9%) |
Dec 2024 | -60.44%(+87.4%) | -63.43%(+26.4%) |
Sep 2024 | - | -86.15%(+20.6%) |
Jun 2024 | - | -108.45%(+47.3%) |
Mar 2024 | - | -205.66%(+27.7%) |
Dec 2023 | -481.35%(+0.0%) | -284.41%(+35.0%) |
Sep 2023 | - | -437.63%(+58.3%) |
Jun 2023 | - | -1048.41%(-238.8%) |
Mar 2023 | - | 755.56%(+206.1%) |
Dec 2022 | -481.49%(-648.8%) | -711.81%(-133.1%) |
Sep 2022 | - | -305.35%(-58.4%) |
Jun 2022 | - | -192.79%(-108.3%) |
Mar 2022 | - | -92.56%(-42.4%) |
Dec 2021 | -64.30%(-708.9%) | -65.00%(-34.9%) |
Sep 2021 | - | -48.20%(-32.7%) |
Jun 2021 | - | -36.32%(-794.6%) |
Mar 2021 | - | -4.06%(-159.9%) |
Dec 2020 | 10.56%(-90.7%) | 6.78%(-71.3%) |
Sep 2020 | - | 23.64%(-64.0%) |
Jun 2020 | - | 65.62%(-67.4%) |
Mar 2020 | - | 201.31%(+26.5%) |
Dec 2019 | 113.79%(+152.7%) | 159.13%(+104.8%) |
Sep 2019 | - | -3322.04%(-685.5%) |
Jun 2019 | - | -422.91%(-97.7%) |
Mar 2019 | - | -213.96%(-43.5%) |
Dec 2018 | -215.72%(-301.7%) | -149.05%(-202.7%) |
Sep 2018 | - | -49.24%(-1182.3%) |
Jun 2018 | - | -3.84%(-110.7%) |
Mar 2018 | - | 35.94%(-61.5%) |
Dec 2017 | 106.97%(+244.1%) | 93.43%(-28.4%) |
Sep 2017 | - | 130.55%(+75.4%) |
Jun 2017 | - | 74.43%(+514.0%) |
Mar 2017 | - | -17.98%(+76.7%) |
Dec 2016 | -74.24%(-183.5%) | -77.12%(-244.5%) |
Sep 2016 | - | 53.36%(+64.6%) |
Jun 2016 | - | 32.42%(-24.8%) |
Mar 2016 | - | 43.09%(-59.4%) |
Dec 2015 | 88.90%(+107.7%) | 106.06%(+145.8%) |
Sep 2015 | - | -231.64%(-76.2%) |
Jun 2015 | - | -131.49%(-14.3%) |
Mar 2015 | - | -115.06%(+51.0%) |
Dec 2014 | -1156.13%(-160.9%) | -234.73%(-27.8%) |
Sep 2014 | - | -183.65%(+28.4%) |
Jun 2014 | - | -256.56%(+47.7%) |
Mar 2014 | - | -490.61%(+63.0%) |
Dec 2013 | -443.11%(-4037.3%) | -1324.61%(-127.1%) |
Sep 2013 | - | -583.15%(-152.2%) |
Jun 2013 | - | -231.20%(-424.6%) |
Mar 2013 | - | -44.07%(-301.4%) |
Dec 2012 | -10.71%(+59.7%) | -10.98%(+77.3%) |
Sep 2012 | - | -48.27%(-132.3%) |
Jun 2012 | - | -20.78%(-73.5%) |
Mar 2012 | - | -11.98%(+55.1%) |
Dec 2011 | -26.55%(-20.1%) | -26.69%(-123.9%) |
Sep 2011 | - | -11.92%(+55.3%) |
Jun 2011 | - | -26.67%(+6.6%) |
Mar 2011 | - | -28.55%(-21.5%) |
Dec 2010 | -22.11% | -23.49%(+47.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | -44.30%(-41.9%) |
Jun 2010 | - | -31.23%(-44.1%) |
Mar 2010 | - | -21.67%(-70.6%) |
Dec 2009 | -24.49%(-4.6%) | -12.70%(+71.2%) |
Sep 2009 | - | -44.17%(+9.7%) |
Jun 2009 | - | -48.91%(+12.4%) |
Mar 2009 | - | -55.83%(+12.0%) |
Dec 2008 | -23.42%(+60.4%) | -63.44%(-134.1%) |
Sep 2008 | - | -27.10%(+29.3%) |
Jun 2008 | - | -38.34%(+28.7%) |
Mar 2008 | - | -53.79%(+10.4%) |
Dec 2007 | -59.12%(-34.1%) | -60.06%(-1.9%) |
Sep 2007 | - | -58.96%(-6.2%) |
Jun 2007 | - | -55.50%(-21.5%) |
Mar 2007 | - | -45.69%(-4.3%) |
Dec 2006 | -44.09%(-63.8%) | -43.79%(-4.9%) |
Sep 2006 | - | -41.73%(+0.1%) |
Jun 2006 | - | -41.79%(-9.1%) |
Mar 2006 | - | -38.32%(-45.6%) |
Dec 2005 | -26.92%(-324.9%) | -26.32%(-93.7%) |
Sep 2005 | - | -13.59%(-6008.7%) |
Jun 2005 | - | 0.23%(-97.0%) |
Mar 2005 | - | 7.63%(-36.3%) |
Dec 2004 | 11.97%(+278.7%) | 11.98%(+115.9%) |
Sep 2004 | - | 5.55%(+3164.7%) |
Jun 2004 | - | 0.17%(-80.5%) |
Mar 2004 | - | 0.87%(+104.6%) |
Dec 2003 | -6.70%(-122.1%) | -19.02%(+52.3%) |
Sep 2003 | - | -39.89%(-234.1%) |
Jun 2003 | - | -11.94%(-0.4%) |
Mar 2003 | - | -11.89%(-487.3%) |
Dec 2002 | 30.36%(+197.2%) | 3.07%(-37.9%) |
Sep 2002 | - | 4.94%(+115.0%) |
Jun 2002 | - | -32.95%(-13.3%) |
Mar 2002 | - | -29.09%(-14.7%) |
Dec 2001 | -31.25%(+36.2%) | -25.37%(-470.9%) |
Sep 2001 | - | 6.84%(+81.4%) |
Jun 2001 | - | 3.77%(-47.4%) |
Mar 2001 | - | 7.17%(+119.0%) |
Dec 2000 | -48.96%(+1.8%) | -37.83%(+44.2%) |
Sep 2000 | - | -67.85%(+24.2%) |
Jun 2000 | - | -89.53%(+20.1%) |
Mar 2000 | - | -112.11%(-152.6%) |
Dec 1999 | -49.86%(-2.3%) | -44.39%(+24.9%) |
Sep 1999 | - | -59.12%(-7.8%) |
Jun 1999 | - | -54.82%(-17.3%) |
Mar 1999 | - | -46.74%(+22.1%) |
Dec 1998 | -48.76%(-34.1%) | -60.01%(-26.4%) |
Sep 1998 | - | -47.47%(+10.3%) |
Jun 1998 | - | -52.92%(+15.4%) |
Mar 1998 | - | -62.58%(-11.8%) |
Dec 1997 | -36.36%(-21.7%) | -55.99%(-54.0%) |
Sep 1997 | - | -36.36%(-21.7%) |
Jun 1997 | - | -29.87%(+2.8%) |
Mar 1997 | - | -30.74%(+51.9%) |
Dec 1996 | -29.87% | -63.89%(-118.1%) |
Sep 1996 | - | 353.33%(+35.9%) |
Jun 1996 | - | 260.00%(+160.0%) |
Mar 1996 | - | 100.00% |
FAQ
- What is Avadel Pharmaceuticals plc annual return on equity?
- What is the all-time high annual ROE for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual ROE year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly return on equity?
- What is the all-time high quarterly ROE for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly ROE year-on-year change?
What is Avadel Pharmaceuticals plc annual return on equity?
The current annual ROE of AVDL is -60.44%
What is the all-time high annual ROE for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual return on equity is 113.79%
What is Avadel Pharmaceuticals plc annual ROE year-on-year change?
Over the past year, AVDL annual return on equity has changed by +420.91% (+87.44%)
What is Avadel Pharmaceuticals plc quarterly return on equity?
The current quarterly ROE of AVDL is -3.81%
What is the all-time high quarterly ROE for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly return on equity is 755.56%
What is Avadel Pharmaceuticals plc quarterly ROE year-on-year change?
Over the past year, AVDL quarterly return on equity has changed by +104.64% (+96.49%)